Cathelicidin LL-37: A Multitask Antimicrobial Peptide

被引:0
|
作者
Robert Bucki
Katarzyna Leszczyńska
Andrzej Namiot
Wojciech Sokołowski
机构
[1] University of Pennsylvania,Institute for Medicine and Engineering
[2] Medical University of Bialystok,Department of Diagnostic Microbiology
[3] Medical University of Bialystok,Department of Anatomy
来源
Archivum Immunologiae et Therapiae Experimentalis | 2010年 / 58卷
关键词
Antibacterial agents; Bacteria; Infection; hCAP-18;
D O I
暂无
中图分类号
学科分类号
摘要
The antimicrobial peptide LL-37 is the only known member of the cathelicidin family of peptides expressed in humans. LL-37 is a multifunctional host defense molecule essential for normal immune responses to infection and tissue injury. LL-37 peptide is a potent killer of different microorganisms with the ability to prevent immunostimulatory effects of bacterial wall molecules such as lipopolysaccharide and can therefore protect against lethal endotoxemia. Additional reported activities of LL-37 include chemoattractant function, inhibition of neutrophil apoptosis, and stimulation of angiogenesis, tissue regeneration, and cytokine release (e.g. IL-8). Cellular production of LL-37 is affected by multiple factors, including bacterial products, host cytokines, availability of oxygen, and sun exposure through the activation of CAP-18 gene expression by vitamin D3. At infection sites, the function of LL-37 can be inhibited by charge-driven interactions with DNA and F-actin released from dead neutrophils and other cells lysed as the result of inflammation. A better understanding of LL-37’s biological properties is necessary for its possible therapeutic application for immunomodulatory purposes as well as in treating bacterial infection.
引用
收藏
页码:15 / 25
页数:10
相关论文
共 50 条
  • [11] Human antimicrobial peptide LL-37
    Yang, YH
    Ma, WR
    Zheng, GG
    Wu, KF
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2003, 30 (06) : 847 - 851
  • [12] Cathelicidin antimicrobial peptide LL-37 enables uptake of dsDNA into human epidermal keratinocytes
    Dombrowski, Y.
    Peric, M.
    Koglin, S.
    Ruzicka, T.
    Besch, R.
    Schauber, J.
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (02) : 179 - 179
  • [13] The Role of Bacterial Filamentation in the Protection Against Human Cathelicidin Antimicrobial Peptide LL-37
    Porco, N.
    Tomlinson, M.
    Botelho, R. J.
    McPhee, J. B.
    MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 378 - 378
  • [14] Serum concentrations of antimicrobial peptide cathelicidin LL-37 in patients with bacterial lung infections
    Majewski, Karol
    Kozlowska, Elzbieta
    Zelechowska, Paulina
    Brzezinska-Blaszczyk, Ewa
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 43 (04) : 453 - 457
  • [15] Cathelicidin Antimicrobial Peptide LL-37 in Cholesteatoma Enables Keratinocyte Reactivity with Cytosolic DNA
    Chi, Z.
    Wang, Z.
    Wang, K.
    Zhu, Y.
    Qin, S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (03) : 214 - 221
  • [16] Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model
    Nagaoka, Isao
    Tamura, Hiroshi
    Reich, Johannes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 16
  • [17] The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds
    Duplantier, Allen J.
    van Hoek, Monique L.
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [18] Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease
    Miao, Shuo
    Liu, Houde
    Yang, Qingyu
    Zhang, Yaping
    Chen, Tao
    Chen, Shuai
    Mao, Xin
    Zhang, Qingsong
    PHARMACOLOGICAL RESEARCH, 2024, 210
  • [19] A comprehensive summary of LL-37, the factotum human cathelicidin peptide
    Vandamme, Dieter
    Landuyt, Bart
    Luyten, Walter
    Schoofs, Liliane
    CELLULAR IMMUNOLOGY, 2012, 280 (01) : 22 - 35
  • [20] Cathelicidin LL-37: LPS-neutralizing, pleiotropic peptide
    Golec, Marcin
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2007, 14 (01) : 1 - 4